RNA Hairpin Molecules as Immunooncology Agents
A short hairpin RNA, alone or in combination with anti-PD1 therapy, activates Rig-I and stimulates immune response
- Stem Loop RNA 14 (SLR14) induces interferon production as a RIG-I agonist.
- Efficacy demonstrated in mouse in vivo tumor models.
- Combination augments efficacy of anti PD-1 therapy.
- Has abscopal and memory effects.
IP status: US62/743369, US2016/0046942, WO2014159990
Innovators: Anna Pyle, Ph.D., Akiko Iwasaki, Ph.D.